Acute cardiac care & resuscitationSecondary analysis

Prognostic performance of cardiogenic shock 4 proteins prediction model in infarct-related cardiogenic shock

ESC Heart FailPublished

  • post-hoc analysis of the randomized CULPRIT-SHOCK trial

Authors' conclusion

The CS4P score provides acceptable short-term mortality risk stratification among patients with CS due to acute myocardial infarction. The CS4P prediction model exhibits superior prognostication among CS patients with STEMI as compared to NSTEMI and in STEMI patients without CPR prior to hospital presentation.

Study context

Population
Patients with cardiogenic shock (CS) presenting with ST-segment elevation myocardial infarction (STEMI) vs non-ST-segment elevation myocardial infarction (NSTEMI), with and without cardiopulmonary resuscitation (CPR)patients with CS included in this study · STEMI 240 · NSTEMI 172
Participants
412 patients
Comparison
STEMI vs NSTEMI
  • STEMIn = 240
  • NSTEMIn = 172
Primary endpoint
Composite of:
  • Mortality
  • Necessity for renal replacement therapy
Follow-up
30-day follow-up

Primary result

As reported in the abstract

STEMI

0.74

AUC · 95% CI 0.67–0.80

NSTEMI

0.69

AUC · 95% CI 0.61–0.77

P = 0.05

Further findings

OutcomeValueshazard ratio (95% CI)P value
Mortality · within 30 days · higher mortality in highest tertile1.42 (1.11–1.82)P = 0.005
OutcomeValuesEstimateP value
Prognostic performance of CS4P score in STEMI by prior CPR · higher prognostic performance without CPRSTEMI patients who had not undergone CPR prior to enrolment AUC 0.78 (95% CI 0.65–0.84) · STEMI patients with preceding CPR AUC 0.70 (95% CI 0.62–0.79)P < 0.001

Original publication

Prognostic performance of cardiogenic shock 4 proteins prediction model in infarct-related cardiogenic shock. ESC Heart Fail. Published 20 January 2026. doi:10.1093/eschf/xvag010

Summarised from the published abstract; every number is checked against it